Aurobindo Pharma Shares Rise 5% in 14 Days Since Subsidiary Launched First US Inhalation Product
Aurobindo Pharma subsidiary Lannett launches generic Advair Diskus in the US, marking its first inhalation product entry into the $908M respiratory market.



















